Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling

Nature Reviews Cancer

Volumn 4, Issue 1, 2004, Pages 23-35

  Bowden, G Tim ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BETA CAROTENE; CELL DNA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIMETHYLBENZ[A]ANTHRACENE; EPIGALLOCATECHIN GALLATE; ETRETINATE; GLYCOGEN SYNTHASE KINASE 3BETA; ISOTRETINOIN; LIPOXYGENASE; MITOGEN ACTIVATED PROTEIN KINASE; NORDIHYDROGUAIARETIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C FOS; PROTEIN C JUN; PROTEIN KINASE B; RAC PROTEIN; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; RETINOIC ACID; RETINOL; SELENIUM; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 1; TRANSCRIPTION FACTOR FRA 2; UNINDEXED DRUG;

CANCER PREVENTION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CYCLIC AMP RESPONSIVE ELEMENT; ENZYME ACTIVATION; GENE MUTATION; HUMAN; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN TARGETING; RADIATION CARCINOGENESIS; REVIEW; SERUM RESPONSIVE ELEMENT; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET B RADIATION;

EID: 0345862188     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1253     Document Type: Review

References (151)

1. Johnson, T. M. at al. Clinical and histologic trends of melanoma. J. Am. Acad. Dermatol. 38, 681-686 (1996).
2. Diepgen, T. L. & Mahler, V. The epidemiology of skin cancer. Br. J. Dermatol. 146 (Suppl 61), 1-6 (2002).
3. Greenlee, R. T., Murray, T. Bolden, S. & Wingo, P. A. Cancer statistics, 2000. CA Cancer J. Clin. 50, 7-33 (2000).
4. Marks, R. An overview of skin cancers, Incidence and causation. Cancer 75, 607-612 (1995). Skin cancer incidence rates are increasing in the United States and in many other countries. Therefore, skin cancer has become a significant public health problem.
5. Moller, R., Reymann, F. & Hou-Jensen, K. Metastases in dermatological patients with squamous cell carcinoma. Arch. Dermatol. 115, 703-705 (1979).
6. Frankel, D. H., Hanusa, B. H. & Zitelli, J. A. New primary nonmelanoma skin cancer in patients with a history of squamous cell carcinoma of the skin. Implications and recommendations for follow-up. J. Am. Acad Dermatol. 26, 720-726 (1992).
7. Karagas, M. R. et al. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group. JAMA 267, 3305-3310 (1992).
8. Preston, D. S. & Stern, R. S. Nonmelanoma cancers of the skin. N. Engl. J. Med. 327, 1649-1662 (1992).
9. Kwa, R. E., Campana, K. & Moy, R. L. Biology of cutaneous squamous cell carcinoma. J. Am. Acad. Dermatol. 26, 1-26 (1992).
10. Baade, P. D., Balanda, K. P. & Lowe, J. B. Changes in skin protection behaviors, attitudes, and sunburn: in a population with the highest incidence of skin cancer in the world. Cancer Detect. Prev. 20, 566-575 (1996).
11. Naylor, M. F. et al. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch. Dermatol. 131, 170-175 (1995).
12. Harvey, I., Frankel, S., Marks, R., Shalom, D. & Nolan-Farrell, M. Non-melanoma skin cancer and solar keratoses II analytical results of the South Wales Skin Cancer Study. Br. J. Cancer 74, 1308-1312 (1996).
13. Graham, S. et al. An inquiry into the epidemiology of melanoma. Am. J. Epidemiol. 122, 606-619 (1985)
14. Wolf, P., Donawho, C. K. & Kripke, M. L. Effect of sunscreens on UV radiation-induced enhancement of melanoma growth in mice. J. Natl Cancer Inst. 86, 99-105 (1994).
15. Tornaletti, S., Rozek, D. & Pfeifer, G. P. The distribution of UV photoproducts along the human p53 gene and its relation to mutations in skin cancer. Oncogene 8, 2051-2057 (1993).
16. Brash, D. E. et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl Acad. Sci. USA 88, 10124-10128 (1991) This is one of the first reports of TP53 tumour-suppressor gene mutations found in skin tumours that are induced by UV light.
17. Matsui, M. S. & DeLeo, V. A. Photocarcinogenesis by ultraviolet A and B. in Skin Cancer: Mechanisms and Human Relevance (ed. Mukhtar, H.) 21-30 (CRC Press, Boca Raton, 1995).
18. DiGiovanni, J. Multistage carcinogenesis in mouse skin. Pharmacol. Ther 54, 63-128 (1992). This review focuses on the mechanisms that are involved in multistage carcinogenesis using the mouse skin model and the relevance of this mouse model to human cancer.
19. Finch, J. S., Albino, H. E. & Bowden, G. T. Quantitation of early clonal expansion of two mutant 61st codon c-Ha-ras alleles in DMBA/TPA treated mouse skin by nested PCR/RFLP. Carcinogenesis 17, 2551-2557 (1996).
20. Domann, F. E. Jr, Levy, J. P., Finch, J. S. & Bowden, G. T. Constitutive AP-1 DNA binding and transactivating ability of malignant but not benign mouse epidermal cells. Mol. Carcinog. 9, 61-66 (1994).
21. Willis, I., Menter, J. M. & Whyte, H. J. The rapid induction of cancers in the hairless mouse utilizing the principle of photoaugmentation. J. Invest. Dermatol. 76, 404-408 (1981)
22. Strickland, P. T. Photocarcinogenesis by near-ultraviolet (UVA) radiation in Sencar mice. J. Invest. Dermatol. 87, 272-275 (1986).
23. Ananthaswamy, H. N. & Pierceall, W. E. Molecular mechanisms of ultraviolet radiation carcinogenesis. Photochem. Photobiol. 52, 1119-1136 (1990).
24. Elmets, C. A. Cutaneous Photocarcinogenesis. in Pharmacology of the Skin (ed. Mukhtar, H.) (CRC Press, Boca Raton, 1992).
25. Ziegler, A. et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc. Natl Acad. Sci. USA 90, 4216-4220 (1993)
26. Kanjilal, S. et al. p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. Cancer Res. 55, 3604-3609 (1995).
27. Campbell, C., Quinn, A. G., Ro, Y. S., Angus, B., & Rees, J. L. p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. J. Invest. Dermatol. 100, 746-748 (1993).
28. Nelson, M. A. et al. Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett. 85, 23-29 (1994).
29. Ziegler, A. et al. Sunburn and p53 in the onset of skin cancer. Nature 372, 773-776 (1994).
30. Yuspa, S. H. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis: thirty-third G. H. A. Clowes Memorial Award Lecture. Cancer Res. 54, 1176-1189 (1994).
31. Zhang, W., Remenyik, E., Zelterman, D., Brash, D. E. & Wikonkal, N. M. Escaping the stem cell compartment: sustained UVB exposure allows p53-mutant keratinocytes to colonize adjacent epidermal proliferating units without incurring additional mutations. Proc. Natl Acad. Sci. USA 98, 13948-13953 (2001).
32. Bode, A. M. & Dong, Z. Mitogen-activated protein kinase activation in UV-induced signal transduction. Sci. STKE 28 Jan 2003 (doi: 10.1126/stke.2003.167.re2) This is an excellent review that focuses on the mechanistic data supporting a role for the MAPKs in UV-light-induced skin carcinogenesis.
33. Grether-Beck, S., Buettner, R. & Krutmann, J. Ultraviolet A radiation-induced expression of human genes: molecular and photobiological mechanisms. Biol. Chem. 378, 1231-1236 (1997).
34. Tyrrell, R. M. Activation of mammalian gene expression by the UV component of sunlight: from models to reality. Bioessays 18, 139-148 (1996).
35. Krutmann, J. Ultraviolet A radiation-induced immunomodulation: molecular and photobiological mechanims. Eur J. Dermatol. 8, 200-202 (1998).
36. Bender, K. et al. UV-induced signal transduction. J. Photochem. Photobiol. B 37, 1-17 (1997).
37. Gallagher, T. F. et al. Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase. Bioorg. Med. Chem. 5, 49-64 (1997).
38. Iordanov, M. et al. CREB is activated by UVC through a p38/HOG-1-dependent protein kinase. EMBO J. 16, 1009-1022 (1997).
39. Wan, Y. S., Wang, Z. Q., Shao, Y., Voorhees, J. J. & Fisher, G. J. Ultraviolet irradiation activates PI 3-kinase/AKT survival pathway via EGF receptors in human skin in vivo. Int. J. Oncol. 18, 461-466 (2001). In this paper the authors demonstrate in human skin that UV activation of the EGF receptor mediates signalling through the PI3K/AKT survival pathway.
40. Chen, W., Tang, Q., Gonzales, M. S. & Bowden, G. T. Role of p38 MAP kinases and ERK in mediating ultraviolet-B induced cyclooxygenase-2 gene expression in human keratinocytes. Oncogene 20, 3921-3926 (2001).
41. Kabuyama, Y. Hamaya, M. & Homma, Y. Wavelength specific activation of PI 3-kinase by UVB irradiation, FEBS Lett. 441, 297-301 (1998).
42. Slaga, T. J., Budunova, I. V., Gimenez-Conti, I. B. & Aldaz, C. M. The mouse skin carcinogenesis model. J. Investig. Dermatol. Symp. Proc. 1, 151-156 (1996).
43. Tennenbaum, T., Belanger, A. J., Quaranta, V. & Yuspa, S. H. Differential regulation of integrins and extracellular matrix binding in epidermal differentiation and squamous tumor progression. J. Investig. Dermatol. Symp. Proc. 1, 157-161 (1996).
44. Fusenig, N. E. & Boukamp, P. Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes. Mol. Carcinog, 23, 144-158 (1998).
45. Zoumpourlis V., Solakidi, S., Papathoma, A. & Papaevangeliou, D. Alterations in signal transduction pathways implicated in tumour progression during multistage mouse skin carcinogenesis. Carcinogenesis 24, 1159-1165 (2003).
46. Bernstein, L. R. & Colburn, N. H. AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science 244, 566-569 (1989).
47. Shaulian, E. & Karin, M. AP-1 as a regulator of cell life and death. Nature Cell Biol. 4, E131-E136 (2002).
48. Chen, W., Borchers, A. H., Dong, Z., Powell, M. B. & Bowden, G. T. UVB irradiation-induced activator protein-1 activation correlates with increased c-fos gene expression in a human keratinocyte cell line. J. Biol. Chem. 273, 32176-32181 (1998).
49. Coso, O. A. et al. Transforming G protein-coupled receptors potently activate JNK (SAPK). Evidence for a divergence from the tyrosine kinase signaling pathway. J. Biol. Chem. 270, 5620-5624 (1995).
50. Domann, F. E., Levy, J. P., Birrer, M. J. & Bowden, G. T. Stable expression of a c-JUN deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice. Cell Growth Differ. 5, 9-16 (1994).
51. Bair, W. B. et al. Inhibitory effects of sodium salicylate and acteylsalicylic acid in UVB-induced mouse skin carcinogenesis. Cancer Epidemiol. Biomarkers Prev. 11, 1645-1652 (2002).
52. Liu, G., Ma, W. Y., Bode, A. M., Zhang, Y. & Dong, Z. NS-398 and piroxicam suppress LJVB-induced activator protein 1 activity by mechanisms independent of cyclooxygenase-2. J. Biol. Chem. 278, 2124-2130 (2003).
53. Barthelman, M. et al. Inhibitory effects of perillyl alcohol on UVB-induced murine skin cancer and AP-1 transactivation. Cancer Res. 58, 711-716 (1998).
54. Young, M. R. et al. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc. Natl Acad. Sci. USA 96, 9827-9832 (1999). In this paper it is shown for the first time that there is a functional role in transgenic mice for AP-1 activation in skin tumour promotion.
55. Thompson, E. J., MacGowan, J., Young, M. R. Colburn, N. & Bowden, G. T. A Dominant negative c-jun specifically blocks okadaic acid-induced skin tumor promotion Cancer Res. 62, 3044-3047 (2002).
56. Cooper, S. J. et al. Expression of dominant negative c-jun inhibits ultraviolet b-induced squamous cell carcinoma number and size in an skh-1 hairless mouse model. Mol. Cancer Res 1, 848-854 (2003). Data presented in this article support the idea that activation of the transcription factor complex, activator protein-1 (AP-1) has a functional role in UVB-light-induced mouse-skin carcinogenesis.
57. Ruther, U., Garber, C., Komitowski, D., Muller, R. & Wagner, E. F. Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature 325, 412-416 (1987).
58. Ruther, U., Komitowski, D., Schubert, F. R. & Wagner, E. F. c-fos expression induces bone tumors in transgenic mice. Oncogene 4, 861-865 (1989).
59. Saez, E. et al. c-fos is required for malignant progression of skin tumors. Cell 82, 721-732 (1995).
60. Robertson, L. M. et al. Regulation of c-fos expression in transgenic mice requires multiple interdependent transcription control elements. Neuron 14, 241-252 (1995).
61. Wang, Y. & Prywes, R. Activation of the c-fos enhancer by the erk MAP kinase pathway through two sequence elements: the c-fos AP-1 and p62TCF sites. Oncogene 19, 1379-1385 (2000).
62. Gonzales, M. & Bowden, G. T. Ultraviolet B (UVB) induction of the c-fos promoter is mediated by phospho-cAMP response element binding protein (CREB) binding to CRE and c-fos activator protein 1 site (FAP1) cis elements. Gene 293, 169-179 (2002).
63. Buscher, M., Rahmsdorf, H. J., Litfin, M., Karin, M. & Herrlich, P. Activation of the c-fos gene by UV and phorbol ester: different signal transduction pathways converge to the same enhancer element. Oncogene 3, 301-311 (1988).
64. Chen, W. & Bowden, G. T. Activation of p38 MAP kinase and ERK are required for ultraviolet-B induced c-fos gene expression in human keratinocytes. Oncogene 18, 7469-7476 (1999).
65. Chen, W. & Bowden, G. T. Role of p38 mitogen-activated protein kinases in ultraviolet-B irradiation-induced activator protein 1 activation in human keratinocytes. Mol. Carcinog. 28, 196-202 (2000). This article contains data that support the role of p38 in UVB-light-induced AP-1 activation in human keratinocytes.
66. Fischer, S. M. et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol. Carcinog. 25, 231-240 (1999).
67. Pentland, A. P., Schoggins, J. W., Scott, G. A., Khan, K. N. & Han, R. Reduction of UV-induced skin tumors in haidess mice by selective COX-2 inhibition. Carcinogenesis 20, 1939-1944 (1999).
68. Buckman, S. Y. et al. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 19, 723-729 (1998)
69. An, K. P. et al. Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: implications for therapeutic approaches. Photochem. Photobiol. 76, 73-80 (2002). This article describes upregulated expression of COX2 in UVB-irradiated mouse and human skin and constitutive overexpression of COX2 in mouse and human skin squamous-cell carcinomas.
70. Higashi, Y., Kanekura, T. & Kanzaki, T. Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: evidence for growth suppression by inhibiting COX-2 expression. Int. J. Cancer 86, 667-671 (2000).
71. Lozano, Y., Taitz, A., Petruzzelli, G. J., Djordjevic, A. & Young, M. R. Prostaglandin E2-protein kinase A signaling and protein phosphatases-1 and-2A regulate human head and neck squamous cell carcinoma motility, adherence, and cytoskeletal organization. Prostaglandins 51, 35-48 (1996).
72. Smith, W. L., Garavito, R. M. & DeWitt, D. L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and-2. J. Biol. Chem. 271, 33157-33160 (1996).
73. Grewe, M. et al. Analysis of the mechanism of ultraviolet (UV) B radiation-induced prostaglandin E2 synthesis by human epidermoid carcinoma cells. J. Invest. Dermatol. 101, 528-531 (1993).
74. Vane, J. R., Bakhle, Y. S. & Botting, R. M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol Toxicot. 38, 97-120 (1998).
75. Gresham, A., Masferrer, J., Chen, X., Leal-Khouri, S. & Pentland, A. P. Increased synthesis of high-molecular-weight cPLA2 mediates early UV-induced PGE2 in human skin. Am. J. Physiol. 270, C1037-C1050 (1996).
76. Kang-Rotondo, C. H., Miller, C. C., Morrison, A. R. & Pentland, A. P. Enhanced keratinocyte prostaglandin synthesis after UV injury is due to increased phospholipase activity. Am. J. Physiol. 264, C396-C401 (1993).
77. Bennett, A., Carroll, M. A., Stamford, I. F., Whimster, W. F. & Williams, F. Prostaglandins and human lung carcinomas. Br. J. Cancer 46, 888-893 (1982).
78. Rigas, B., Goldman, I. S. & Leche, L. Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med. 122, 518-523 (1993).
79. Tsujii, M. et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93, 705-716 (1998).
80. Sheng, H., Shao, J., Morrow, J. D., Beauchamp, R. D. & DuBois, R. N. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res. 58, 362-366 (1998).
81. Marks, F. & Furstenberger, G. Cancer chemoprevention through interruption of multistage carcinogenesis. The lessons leamt by comparing mouse skin carcinogenesis and human large bowel cancer. Eur. J. Cancer 36, 314-329 (2000).
82. Tang, Q. et al. Role of cyclic AMP responsive element in the UVB induction of cyclooxygenase-2 transcription in human keratinocytes. Oncogene 20, 5164-5172 (2001)
83. Xie, W. & Herschman, H. R. v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor. J. Biol. Chem. 270, 27622-27628 (1995).
84. Xie, W. & Herschman, H. R. Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum. J. Biol. Chem. 271, 31742-31748 (1996).
85. Zhang, F., Subbaramaiah, K., Altorki, N. & Dannenberg, A. J. Dihydroxy bile acids activate the transcription of cyclooxygenase-2. J. Biol. Chem. 273, 2424-2428 (1998).
86. Inoue, H., Yokoyama, C., Hara, S., Tone, Y. & Tanabe, T. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J. Biol. Chem. 270, 24965-24971 (1995).
87. Subbaramaiah, K., Hart, J. C., Norton, L. & Dannenberg, A. J. Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 AND p38 mitogen-activated protein kinase pathways. J. Biol. Chem. 275, 14838-14845 (2000).
88. Inoue, H. & Tanabe, T. Transcriptional role of the nuclear factor κB site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells, Biochem. Biophys. Res. Commun. 244, 143-148 (1998).
89. Carpenter, C. L. et al. Purification and characterization of phosphoinositide 3-kinase from rat liver. J. Biol. Chem. 265, 19704-19711 (1990).
90. Roymans, D. & Slegers, H. Phosphatidylinositol 3-kinases in tumor progression. Eur. J. Biochem. 268, 487-498 (2001).
91. Gonzales, M. & Bowden, G. T. The role of PI 3-kinase in the UVB-induced expression of c-fos. Oncogene 21, 2721-2728 (2002).
92. Nomura, M. et al. Inhibitory mechanisms of tea polyphenols on the ultraviolet B-activated phosphatidylinositol 3-kinase-dependent pathway. J. Biol. Chem. 276, 48824-48631 (2001).
93. + cells. Mol. Cell. Biol. 16, 8427-6435 (1996).
94. Jhun, B. H. et al. Microinjection of the SH2 domain of the 85-kilodalton subunit of phosphatidylinositol 3-kinase inhibits insulin-induced DNA synthesis and c-fos expression. Mol. Cell. Biol. 14, 7466-7475 (1994).
95. Tang, Q., Gonzales, M., Inoue, H. & Bowden, G. T. Roles of Akt and glycogen synthase kinase 3β in the ultraviolet B induction of cyclooxygenase-2 transcription in human keratinocytes. Cancer Res. 61, 4329-4332 (2001).
96. Zhang, Q. S. et al. Cytokine-induced p38 activation feedback regulates the prolonged activation of AKT cell survival pathway initiated by reactive oxygen species in response to UV irradiation in human keratinocytes. Int. J. Oncol. 19, 1057-1061 (2001).
97. Fisher, G. J. et al. Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo. J. Clin. Invest. 101, 1432-1440 (1998). There is a clear demonstration in this paper that UV irradiation of human skin results in increased epidermal AP-1 DNA binding.
98. Mukhtar, H., Wang, Z. Y., Katiyar, S. K. & Agarwal, R. Tea components: antimutagenic and anticarcinogenic effects. Prev. Med. 21, 351-360 (1992).
99. Yang. C. S., Lee, M. J., Chen, L. & Yang, G. Y. Polyphenols as inhibitors of carcinogeness. Environ. Health Perspect. 105 (Suppl 4), 971-976 (1997). This review article summarises current knowledge of various molecular chemopreventive mechanisms of polyphenols that prevent carcinogenesis in animal models.
100. Huang, M. T., Wang, Z. Y., Georgiadis, C. A., Laskin, J. D. & Conney, A. H. Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7, 12-dimethylbenz[a]anthracene. Carcinogenesis 13, 2183-2186 (1992).
101. Conney, A. H., Wang, Z. Y., Huang, M. T., Ho, C. T. & Yang, C. S. Inhibitory effect of green tea on tumorigenesis by chemicals and ultraviolet light. Prev. Med. 21, 361-369 (1992).
102. Wang, Z. Y. et al. Inhibitory effect of green tea in the drinking water on tumorigenesis by ultraviolet light and 12-O-tetradecanoylphorbol-13-acetate in the skin of SKH-1 mice. Cancer Res. 52, 1162-1170 (1992).
103. Gensler, H. L. et al. Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated from green tea. Nutr. Cancer 26, 325-335 (1996).
104. Katiyar, S. K., Elmets, C. A., Agarwal, R. & Mukhtar, H. Protection against ultraviolet-B radiation-induced local and systemic suppression of contact hypersensitivity and edema responses in C3H/HeN mice by green tea polyphenols. Photochem. Photobiol. 62, 855-861 (1995).
105. Katiyar, S. K., Rupp, C. O., Korman, N. J., Agarwal, R. & Mukhtar, H. Inhibition of 12-O-tetradecanoylphorbol-13-acetate and other skin tumor-promoter-caused induction of epidermal interleukin-1 α mRNA and protein expression in SENCAR mice by green tea polyphenols. J. Invest. Dermatol. 105, 394-398 (1995)
106. Perchellet, J. P. & Perchellet, E. M. Antioxidants and multistage carcinogenesis in mouse skin. Free Radic. Biol. Med. 7, 377-408 (1989).
107. Goldstein, B. D. & Witz, G. Free radicals and carcinogenesis. Free Radic. Res. Commun. 11, 3-10 (1990).
108. Trush, M. A. & Kensler, T. W. An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radic. Biol. Med. 10, 201-209 (1991).
109. Fscher, S. M., Cameron, G. S., Baldwin, J. K., Jasheway, D. W. & Patrick, K. E. Reactive oxygen in the tumor promotion stage of skin carcinogenesis. Lipids 23, 592-597 (1988).
110. Perchellet, J. in Skin Cancer Mechanisms and Human Relevance (ed. Mukhtar, H.) 145 (CRC Press, Florida, 1995)
111. Dong, Z., Ma, W., Huang, C. & Yang, C. S. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins Cancer Res. 57, 4414-4419 (1997).
112. Kitano, K., Nam, K. Y., Kimura, S., Fujiki, H. & Imanishi, Y. Seeding effects of (-)-epigallocatechin gallate on protein kinase C and protein phosphatase 2A. Biophys. Chem. 65, 157-164 (1997).
113. Suganuma, M. et al. A new process of cancer prevention mediated through inhibition of tumor necrosis factor α expression. Cancer Res. 56, 3711-3715 (1996).
114. Barthelman, M. et al. (-)-Epigallocatechin-3-gallate inhibition of ultraviolet B-induced AP-1 activity. Carcinogenesis 19, 2201-2204 (1998).
115. Agarwal, R., Katiyar, S. K., Khan, S. G. & Mukhtar, H. Protection against ultraviolet B radiation-induced effects in the skin of SKH-1 hairless mice by a polyphenolic fraction isolated from green tea. Photochem. Photobiol. 58, 695-700 (1993).
116. Huang, C., Ma, W., Bowden, G. T. & Dong, Z. Ultraviolet B-induced activated protein-1 activation does not require epidermal growth factor receptor but is blocked by a dominant negative PKCλ/ι. J. Biol. Chem. 271, 31262-31268 (1996).
117. Assefa, Z. et al. Differential stimulation of ERK and JNK activities by ultraviolet B irradiation and epidermal growth factor in human keratinocytes. J. Invest. Dermatol. 108, 886-891 (1997).
118. Radler-Pohl, A. et al. UV-induced activation of AP-1 involves obligatory extranuclear steps including Raf-1 kinase. EMBO J. 12, 1005-1012 (1993).
119. Huang, C. et al. Inhibition of atypical PKC blocks ultraviolet-induced AP-1 activation by specifically inhibiting ERKs activation. Mol. Carcinog. 27, 65-75 (2000).
120. Yu, R. et al. Activation of mitogen-activated protein kinases by green tea polyphenols: potential signaling pathways in the regulation of antioxidant-responsive element-mediated phase II enzyme gene expression. Carcinogenesis 18, 451-456 (1997).
121. Chen, W., Dong, Z., Valcic, S., Timmermann, B. N. & Bowden, G. T. Inhibition of ultraviolet B: induced c-fos gene expression and p38 mitogen-activated protein kinase activation by (-)-epigallocatechin gallate in a human keratinocyte cell line Mol. Carcinog. 24, 79-84 (1999).
122. Numazawa, S. et al. Cooperative induction of c-fos and heme oxygenase gene products under oxidative stress in human fibroblastic cells. Exp. Cell. Res. 237, 434-444 (1997).
123. Tao, J., Sanghera, J. S., Pelech, S. L., Wong, G. & Levy, J. G. Stimulation of stress-activated protein kinase and p38 HOG 1 kinase in murine keratinocytes following photodynamic therapy with benzoporphyrin derivative. J. Biol. Chem. 271, 27107-27115 (1996).
124. Yang, C. S. & Wang, Z. Y. Tea and cancer. J. Natl Cancer Inst. 85, 1038-1049 (1993).
125. Hsu, T. C., Young, M. R., Cmarik, J. & Colbum, N. H. Activator protein 1 (AP-1)- and nuclear factor κB(NF-κB)-dependent transcriptional events in carcinogenesis. Free Radic. Biol. Med. 28, 1338-1348 (2000).
126. McCormick, D. L. & Spicer, A. M. Nordihydroguaiaretic acid suppression of rat mammary carcinogenesis induced by N-methyl-N-nitrosourea. Cancer Lett. 37, 139-146 (1987).
127. Nakadate, T., Yamamoto, S., Aizu, E. & Kato, R. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced increase in vascular permeability in mouse skin by lipoxygenase inhibitors. Jpn J. Pharmacol. 38, 161-168 (1985).
128. Birkenfeld, S. et al. Antitumor effects of inhibitors of arachidonic acid cascade on experimentally induced intestinal tumors. Dis. Colon Rectum. 30, 43-46 (1987).
129. Olsen, E. A. et al. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J. Am. Acad. Dermatol. 24, 738-743 (1991).
130. Odom, R. Managing actinic keratoses with retinoids. J. Am. Acad. Dermatol. 39, 74-78 (1998).
131. Nakadate, T. et al. Inhibition of 12-O-tetradecanoyl-phorbol-13-acetate-induced tumor promotion by nordihydroguaiaretic acid, a lipoxygenase inhibitor, and p-bromophenacyl bromide, a phospholipase A2 inhibitor. Gann 73, 841-843 (1982).
132. Park, S., Lee, D. K. & Yang, C. H. Inhibition of fos-jun-DNA complex formation by dihydroguaiaretic acid and in vitro cytotoxic effects on cancer cells. Cancer Lett. 127, 23-28 (1998).
133. Kemal, C., Louis-Flamberg, P., Krupinski-Olsen, R. & Shorter, A. L. Reductive inactivation of soybean lipoxygenase 1 by catechols: a possible mechanism for regulation of lipoxygenase activity. Biochemistry 26, 7064-7072 (1987).
134. Rao, G. N., Glasgow, W. C., Eling, T. E. & Runge, M. S. Role of hydroperoxyeicosatetraenoic acids in oxidative stress-induced activating protein 1 (AP-1) activity J. Biol. Chem. 271, 27760-27764 (1996).
135. Glasgow, W. C., Afshari, C. A., Barrett, J. C. & Eling, T. E. Modulation of the epidermal growth factor mitogenic response by metabolites of linoleic and arachidonic acid in Synan hamster embryo fibroblasts. Differential effects in tumor suppressor gene (+) and (-) H phenotypes. J. Biol. Chem. 267, 10771-10779 (1992).
136. Gonzales, M. & Bowden, G. T. Nordihydroguaiaretic acid-mediated inhibition of ultraviolet B-induced activator protein-1 activation in human keratinocytes. Mol. Carcinog. 34, 102-111 (2002).
137. Einspahr, J. G., Stratton, S. P., Bowden, G. T. & Alberts, D. S. Chemoprevention of human skin cancer. Crit. Rev. Oncol. Hematol. 41, 269-285 (2002). This review describes the translation of laboratory findings concerning UV signal-transduction pathways and pre-clinical studies of chemoprevention agents that target these pathways in patients at high risk for skin cancer.
138. Lippman, S. M. et al. Biomarkers as intermediate end points in chemoprevention trials. J. Natl Cancer Inst. 82, 555-560 (1990).
139. Mehta, K. Retinoids as regulators of gene transcription. J. Biol. Regul. Homeost. Agents 17, 1-12 (2003).
140. Suzukawa, K. & Colburn, N. H. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers. Oncogene 21, 2181-2190 (2002).
141. Benkoussa, M., Brand, C., Delmotte, M. H., Formstecher, P. & Lefebvre, P. Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter. Mol. Cell. Biol. 22, 4522-4534 (2002).
142. Przbyszewski, J. et al. Inhibition of phorbol ester-induced AP-1-DNA binding, c-Jun protein and c-jun mRNA by dietary energy restriction is reversed by adrenalectomy in SENCAR mouse epidermis. Carcinogenesis 22, 1421-1427 (2001).
143. Liu, Y. et al. Dietary energy restriction inhibits ERK but not JNK or p38 activity in the epidermis of SENCAR mice. Carcinogenesis 22, 607-612 (2001).
144. Moon, T. E. et al. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Biomarkers Prev. 6, 949-956 (1997). This paper deals with one positive Phase III clinical trial showing that oral retinol can lower the incidence of SCC, but not BCC.
145. Tangrea, J. A. et al. Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study Group, J. Natl Cancer Inst. 84, 328-332 (1992).
146. Levine, N. et al. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Biomarkers Prev. 6, 957-961 (1997).
147. Greenberg, E. R. et al. A clinical trial of 3 carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group. N. Engl. J. Med. 323, 789-795 (1990).
148. Clark, L. C. et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276, 1957-1963 (1996).
149. Misiewicz, J. et al. Topical treatment of multiple actinic keratoses of the face with arotinoid methyl sulfone (Ro 14-9706) cream versus tretinoin cream: a double-blind, comparative study. J. Am. Acad. Dermatol. 24, 448-451 (1991).
150. Black, H. S. et al. Effect of a low-fat diet on the incidence of actinic keratosis. N. Engl. J. Med. 330, 1272-1275 (1994).
151. Alberts, D. S. et al. Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine. Cancer Epidemiol. Biomarkers Prev. 9, 1281-1286 (2000).